Ethicon Establishes Unmatched Knotless Suture Portfolio With Launch Of Stratafix™ Spiral Plus Devices

August 22, 2016

Cincinnati, OH /PRNewswire/ – Ethicon*, a trusted leader in advancing wound closure, announces the launch of STRATAFIX™ Spiral PDS Plus and STRATAFIX™ Spiral Monocryl Plus Knotless Tissue Control Devices. With the addition of these two new suture technologies to the STRATAFIX™ Family of Knotless Tissue Control Devices, Ethicon has established the most comprehensive and unmatched knotless suture offering available to surgeons in the U.S.

STRATAFIX™ Knotless Tissue Control Devices transforms the wound closure experience by providing unique advantages over traditional sutures. STRATAFIX™ sutures provide more strength and security, more consistency and more efficiency than traditional suturing. The portfolio of knotless sutures also enables surgeons to more easily manage tension and control tissue approximation with each pass during closure and eliminates the need to tie knots.

“I call it the suture of the future,” said James Dan Kondrup**, M.D., Minimally Invasive Gynecologic Surgeon of Lourdes Hospital in Binghamton, NY. “Any case where I can use STRATAFIX sutures, I will.”

The versatile STRATAFIX™ portfolio of knotless sutures will help surgeons to achieve the optimal clinical outcome for each tissue type, from skin and fat layers to fascia*** and organs. STRATAFIX™ Spiral Plus sutures boast exceptional wound holding strength while offering a smooth glide through tissue, and are available in both bidirectional and a unidirectional design with an adjustable fixation loop. These new sutures are made with proprietary polymers, premium needles and Plus antibacterial coating that continue to deliver the optimal wound closure experience surgeons and health care practitioners expect from Ethicon.

“With more than 60 years of experience, Ethicon has become synonymous with surgical sutures,” said Liza Ovington, Franchise Medical Director for Ethicon. “Ethicon will continue to innovate in wound closure working to provide solutions that elevate the standard of care for surgeons and the patients they serve.”

STRATAFIX™ Knotless Tissue Control Devices can address tissue repair needs in a broad range of surgical specialties including orthopaedic, plastic, gynecological, general, bariatric, colorectal, and urological procedures. Additional information about the Ethicon STRATAFIX™ portfolio can be found here:

About Ethicon*
From creating the first sutures, to revolutionizing surgery with minimally invasive procedures, Ethicon has made significant contributions to surgery for more than 60 years. Our continuing dedication to Shape the Future of Surgery is built on our commitment to help address the world’s most pressing health care issues, and improve and save more lives. Through Ethicon’s surgical technologies and solutions including sutures, staplers, energy devices, trocars and hemostats and our commitment to treat serious medical conditions like obesity and cancer worldwide, we deliver innovation to make a life-changing impact. Learn more at, and follow us on Twitter @Ethicon.

*Ethicon, Inc. is the legal manufacturer of STRATAFIX™ Sutures.
**James Kondrup is a paid consultant of Ethicon.
***Fascia indication for STRATAFIX™ Symmetric PDS™ Plus only.

For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.

SOURCE: Ethicon

Copyright 2016 PR Newswire. All Rights Reserved

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button